Could DocuSign Inc (DOCU) stock price achieve new all-time highs if its expected earnings and revenue increase?

In yesterday’s Wall Street session, DocuSign Inc (NASDAQ:DOCU) shares traded at $53.72, up 8.02% from the previous session.

As of this writing, 23 analysts cover DocuSign Inc (NASDAQ:DOCU). The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $90.00 and a low of $44.00, we find $50.00. Given the previous closing price of $49.73, this indicates a potential upside of 0.54 percent. DOCU stock price is now 27.79% away from the 50-day moving average and 7.87% away from the 200-day moving average. The market capitalization of the company currently stands at $10.92B.

There are 14 analysts who have given it a hold rating, whereas 5 have given it a buy rating. Brokers who have rated the stock have averaged $57.60 as their price target over the next twelve months.

With the price target maintained at $42, HSBC Securities recently Upgraded its rating from Reduce to Hold for DocuSign Inc (NASDAQ: DOCU).

In other news, Springer Daniel D., Director sold 289,666 shares of the company’s stock on Oct 10. The stock was sold for $12,319,495 at an average price of $42.53. Upon completion of the transaction, the Director now directly owns 1,051,419 shares in the company, valued at $56.48 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Oct 09, Director Springer Daniel D. sold 289,667 shares of the business’s stock. A total of $12,192,884 was realized by selling the stock at an average price of $42.09. This leaves the insider owning 1,051,419 shares of the company worth $56.48 million. Insiders disposed of 1,733,223 shares of company stock worth roughly $93.11 million over the past 1 year. A total of 1.09% of the company’s stock is owned by insiders.

Monday morning saw DocuSign Inc (NASDAQ: DOCU) opened at $49.67. During the past 12 months, DocuSign Inc has had a low of $38.11 and a high of $69.45. As of last week, the company has a debt-to-equity ratio of 0.87, a current ratio of 0.93, and a quick ratio of 0.93. According to the stock market information, the enterprise value for the company is $10.20B, which is based on a 215.22 price-to-earnings ratio, a 10.76 price-to-earnings-growth ratio, and a beta of 0.92. The fifty day moving average price for DOCU is $42.04 and a two-hundred day moving average price translates $49.80 for the stock.

The latest earnings results from DocuSign Inc (NASDAQ: DOCU) was released for Oct, 2023. According to the Software – Application Company, earnings per share came in at $0.79, beating analysts’ expectations of $0.63 by 0.16. This compares to -$0.15 EPS in the same period last year. The net profit margin was 1.90% and return on equity was 7.20% for DOCU. The company reported revenue of $700.42 million for the quarter, compared to $645.46 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 8.51 percent. For the current quarter, analysts expect DOCU to generate $698.52M in revenue.

DocuSign Inc(DOCU) Company Profile

DocuSign, Inc. provides electronic signature solution in the United States and internationally. The company provides DocuSign e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce. It also provides Identify, a signer-identification option for checking government-issued IDs; Standards-Based Signatures, which support signatures that involve digital certificates; and Monitor that uses advanced analytics to track DocuSign eSignature web, mobile, and API account. In addition, the company offers Rooms for Real Estate that provides a way for brokers and agents to manage the entire real estate transaction digitally; DocuSign Federal and DocuSign CLM are FedRAMP, an authorized version of DocuSign eSignature for U.S. federal government agencies; and life sciences modules that support compliance with the electronic signature practices. The company sells its products through direct and partner-assisted sales, and web-based self-service purchasing. The company was incorporated in 2003 and is headquartered in San Francisco, California.

Related Posts